Helios Intelligence

YC company profile

At-home molecular body test: 1,000+ biomarkers from a drop of blood

Helios is building a molecular body test from a single drop of blood. Our at-home test measures more than 1,000 biomarkers and turns them into a living model of the body—designed to show what is happening now, surface risk earlier, and become more useful with every test.

By combining longitudinal molecular data with labs, wearables, health records, and outcomes, we are building toward a world model of human biology. Our goal is to simulate all of human health and use that intelligence to help people perform, recover, and live longer.

• YC batch: Fall 2026
• Founded: 2025
• Team size: 5
• Location: Boston
• Country: US
• Status: Active
• Industry: Healthcare
• Stage: Early
• Tags: Health Tech, Consumer, Diagnostics, Health & Wellness, AI
• YC partner: Max Kolysh

Founders

Omar Abudayyeh — Founder

Co-founder of Helios Intelligence, the human enhancement company. I completed my PhD training at the Broad Institute and MIT. I've spent many years in academia studying aging and longevity, including as an Asst. Professor at Harvard Medical School, and have co-founded seven biotechnology companies that have raised over $400M, including Sherlock Biosciences (acquired by OraSure, NASDAQ: OSUR), Proof Diagnostics (acquired by Ginkgo Bioworks, NYSE: DNA) and Terrain Biosciences (acquired).

LinkedIn · X

Jonathan Gootenberg — Founder

Founder at Helios Intelligence. Faculty at Harvard Medical School and co-director of the Abudayyeh-Gootenberg Lab. Co-founded Tome Biosciences and Sherlock Biosciences. PhD in Systems Biology from Harvard, advised by Feng Zhang and Aviv Regev at the Broad Institute. BA in Biological Engineering and Mathematics from MIT.

LinkedIn · X

Source: Y Combinator · Retrieved 2026-11-02. Company information is self-reported on YC.